Literature DB >> 20483451

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Kunihiro Matsushita, Marije van der Velde, Brad C Astor, Mark Woodward, Andrew S Levey, Paul E de Jong, Josef Coresh, Ron T Gansevoort.   

Abstract

BACKGROUND: Substantial controversy surrounds the use of estimated glomerular filtration rate (eGFR) and albuminuria to define chronic kidney disease and assign its stages. We undertook a meta-analysis to assess the independent and combined associations of eGFR and albuminuria with mortality.
METHODS: In this collaborative meta-analysis of general population cohorts, we pooled standardised data for all-cause and cardiovascular mortality from studies containing at least 1000 participants and baseline information about eGFR and urine albumin concentrations. Cox proportional hazards models were used to estimate hazard ratios (HRs) for all-cause and cardiovascular mortality associated with eGFR and albuminuria, adjusted for potential confounders.
FINDINGS: The analysis included 105,872 participants (730,577 person-years) from 14 studies with urine albumin-to-creatinine ratio (ACR) measurements and 1,128,310 participants (4,732,110 person-years) from seven studies with urine protein dipstick measurements. In studies with ACR measurements, risk of mortality was unrelated to eGFR between 75 mL/min/1.73 m(2) and 105 mL/min/1.73 m(2) and increased at lower eGFRs. Compared with eGFR 95 mL/min/1.73 m(2), adjusted HRs for all-cause mortality were 1.18 (95% CI 1.05-1.32) for eGFR 60 mL/min/1.73 m(2), 1.57 (1.39-1.78) for 45 mL/min/1.73 m(2), and 3.14 (2.39-4.13) for 15 mL/min/1.73 m(2). ACR was associated with risk of mortality linearly on the log-log scale without threshold effects. Compared with ACR 0.6 mg/mmol, adjusted HRs for all-cause mortality were 1.20 (1.15-1.26) for ACR 1.1 mg/mmol, 1.63 (1.50-1.77) for 3.4 mg/mmol, and 2.22 (1.97-2.51) for 33.9 mg/mmol. eGFR and ACR were multiplicatively associated with risk of mortality without evidence of interaction. Similar findings were recorded for cardiovascular mortality and in studies with dipstick measurements.
INTERPRETATION: eGFR less than 60 mL/min/1.73 m(2) and ACR 1.1 mg/mmol (10 mg/g) or more are independent predictors of mortality risk in the general population. This study provides quantitative data for use of both kidney measures for risk assessment and definition and staging of chronic kidney disease. FUNDING: Kidney Disease: Improving Global Outcomes (KDIGO), US National Kidney Foundation, and Dutch Kidney Foundation. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483451      PMCID: PMC3993088          DOI: 10.1016/S0140-6736(10)60674-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  34 in total

Review 1.  The case for using albuminuria in staging chronic kidney disease.

Authors:  Ron T Gansevoort; Paul E de Jong
Journal:  J Am Soc Nephrol       Date:  2009-03       Impact factor: 10.121

2.  Early identification and management of chronic kidney disease: summary of NICE guidance.

Authors:  Emily Crowe; David Halpin; Paul Stevens
Journal:  BMJ       Date:  2008-09-29

Review 3.  Staging of chronic kidney disease: time for a course correction.

Authors:  Carolyn Bauer; Michal L Melamed; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

4.  Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.

Authors:  Brad C Astor; Stein I Hallan; Edgar R Miller; Edwina Yeung; Josef Coresh
Journal:  Am J Epidemiol       Date:  2008-04-02       Impact factor: 4.897

5.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

6.  All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan.

Authors:  Chi Pang Wen; Ting Yuan David Cheng; Min Kuang Tsai; Yen Chen Chang; Hui Ting Chan; Shan Pou Tsai; Po Huang Chiang; Chih Cheng Hsu; Pei Kun Sung; Yi Hua Hsu; Sung Feng Wen
Journal:  Lancet       Date:  2008-06-28       Impact factor: 79.321

7.  Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study.

Authors:  Stein Hallan; Brad Astor; Solfrid Romundstad; Knut Aasarød; Kurt Kvenild; Josef Coresh
Journal:  Arch Intern Med       Date:  2007-12-10

8.  Dissecting and refining the staging of chronic kidney disease.

Authors:  Christopher G Winearls; Richard J Glassock
Journal:  Kidney Int       Date:  2009-02-25       Impact factor: 10.612

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

Review 10.  Current issues in measurement and reporting of urinary albumin excretion.

Authors:  W Greg Miller; David E Bruns; Glen L Hortin; Sverre Sandberg; Kristin M Aakre; Matthew J McQueen; Yoshihisa Itoh; John C Lieske; David W Seccombe; Graham Jones; David M Bunk; Gary C Curhan; Andrew S Narva
Journal:  Clin Chem       Date:  2008-11-21       Impact factor: 8.327

View more
  1275 in total

1.  Approach to cardiovascular disease prevention in patients with chronic kidney disease.

Authors:  Cristina Karohl; Paolo Raggi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

2.  Primary care management of chronic kidney disease.

Authors:  Adrienne S Allen; John P Forman; E John Orav; David W Bates; Bradley M Denker; Thomas D Sequist
Journal:  J Gen Intern Med       Date:  2010-10-05       Impact factor: 5.128

3.  Contrasting Cholesterol Management Guidelines for Adults with CKD.

Authors:  Lisandro D Colantonio; Usman Baber; Maciej Banach; Rikki M Tanner; David G Warnock; Orlando M Gutiérrez; Monika M Safford; Christoph Wanner; George Howard; Paul Muntner
Journal:  J Am Soc Nephrol       Date:  2014-11-13       Impact factor: 10.121

4.  Chronic kidney disease in octogenarians.

Authors:  Shani Shastri; Hocine Tighiouart; Ronit Katz; Dena E Rifkin; Linda F Fried; Michael G Shlipak; Anne B Newman; Mark J Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

5.  Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.

Authors:  Daniel E Weiner; Meyeon Park; Hocine Tighiouart; Alin A Joseph; Myra A Carpenter; Nitender Goyal; Andrew A House; Chi-Yuan Hsu; Joachim H Ix; Paul F Jacques; Clifton E Kew; S Joseph Kim; John W Kusek; Todd E Pesavento; Marc A Pfeffer; Stephen R Smith; Matthew R Weir; Andrew S Levey; Andrew G Bostom
Journal:  Am J Kidney Dis       Date:  2018-07-20       Impact factor: 8.860

6.  Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.

Authors:  Giuseppe Penno; Anna Solini; Emanuela Orsi; Enzo Bonora; Cecilia Fondelli; Roberto Trevisan; Monica Vedovato; Franco Cavalot; Olga Lamacchia; Marco Scardapane; Antonio Nicolucci; Giuseppe Pugliese
Journal:  Diabetologia       Date:  2018-07-21       Impact factor: 10.122

7.  Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.

Authors:  Benjamin M Scirica; Ofri Mosenzon; Deepak L Bhatt; Jacob A Udell; Ph Gabriel Steg; Darren K McGuire; KyungAh Im; Estella Kanevsky; Christina Stahre; Mikaela Sjöstrand; Itamar Raz; Eugene Braunwald
Journal:  JAMA Cardiol       Date:  2018-02-01       Impact factor: 14.676

8.  Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD.

Authors:  Dominik Steubl; Markus P Schneider; Heike Meiselbach; Jennifer Nadal; Matthias C Schmid; Turgay Saritas; Vera Krane; Claudia Sommerer; Seema Baid-Agrawal; Jakob Voelkl; Fruzsina Kotsis; Anna Köttgen; Kai-Uwe Eckardt; Jürgen E Scherberich
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-14       Impact factor: 8.237

Review 9.  Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.

Authors:  Ankur Jindal; Mariana Garcia-Touza; Nidhi Jindal; Adam Whaley-Connell; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-08-01       Impact factor: 4.741

Review 10.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.